238 related articles for article (PubMed ID: 26307605)
1. Use of an α-Glucosidase Inhibitor and the Risk of Colorectal Cancer in Patients With Diabetes: A Nationwide, Population-Based Cohort Study.
Tseng YH; Tsan YT; Chan WC; Sheu WH; Chen PC
Diabetes Care; 2015 Nov; 38(11):2068-74. PubMed ID: 26307605
[TBL] [Abstract][Full Text] [Related]
2. Sulphonylureas monotherapy and risk of hospitalization for heart failure in patients with type 2 diabetes mellitus: A population-based cohort study in China.
Xu Y; Wang T; Yang Z; Lin H; Shen P; Zhan S
Pharmacoepidemiol Drug Saf; 2020 Jun; 29(6):635-643. PubMed ID: 32383226
[TBL] [Abstract][Full Text] [Related]
3. Acarbose treatment and the risk of cardiovascular disease in type 2 diabetic patients: a nationwide seven-year follow-up study.
Chen JM; Chang CW; Lin YC; Horng JT; Sheu WH
J Diabetes Res; 2014; 2014():812628. PubMed ID: 25197673
[TBL] [Abstract][Full Text] [Related]
4. Comparing the risks of hospitalized heart failure associated with glinide, sulfonylurea, and acarbose use in type 2 diabetes: A nationwide study.
Lee YC; Chang CH; Dong YH; Lin JW; Wu LC; Hwang JS; Chuang LM
Int J Cardiol; 2017 Feb; 228():1007-1014. PubMed ID: 27923207
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular Benefits of Acarbose vs Sulfonylureas in Patients With Type 2 Diabetes Treated With Metformin.
Hsu PF; Sung SH; Cheng HM; Shin SJ; Lin KD; Chong K; Yen FS; Yu BH; Huang CT; Hsu CC
J Clin Endocrinol Metab; 2018 Oct; 103(10):3611-3619. PubMed ID: 30113697
[TBL] [Abstract][Full Text] [Related]
6. Acarbose Decreases the Rheumatoid Arthritis Risk of Diabetic Patients and Attenuates the Incidence and Severity of Collagen-induced Arthritis in Mice.
Chen HH; Chen DY; Chao YH; Chen YM; Wu CL; Lai KL; Lin CH; Lin CC
Sci Rep; 2015 Dec; 5():18288. PubMed ID: 26678745
[TBL] [Abstract][Full Text] [Related]
7. The risk of colorectal cancer in patients with type 2 diabetes: associations with treatment stage and obesity.
Peeters PJ; Bazelier MT; Leufkens HG; de Vries F; De Bruin ML
Diabetes Care; 2015 Mar; 38(3):495-502. PubMed ID: 25552419
[TBL] [Abstract][Full Text] [Related]
8. Association of gout and colorectal cancer in Taiwan: a nationwide population-based cohort study.
Chuang JP; Lee JC; Leu TH; Hidajah AC; Chang YH; Li CY
BMJ Open; 2019 Oct; 9(10):e028892. PubMed ID: 31601586
[TBL] [Abstract][Full Text] [Related]
9. Association of thiazolidinediones with liver cancer and colorectal cancer in type 2 diabetes mellitus.
Chang CH; Lin JW; Wu LC; Lai MS; Chuang LM; Chan KA
Hepatology; 2012 May; 55(5):1462-72. PubMed ID: 22135104
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular risk associated with acarbose versus metformin as the first-line treatment in patients with type 2 diabetes: a nationwide cohort study.
Chang CH; Chang YC; Lin JW; Chen ST; Chuang LM; Lai MS
J Clin Endocrinol Metab; 2015 Mar; 100(3):1121-9. PubMed ID: 25555040
[TBL] [Abstract][Full Text] [Related]
11. Metformin is associated with a lower risk of colorectal cancer in Taiwanese patients with type 2 diabetes: A retrospective cohort analysis.
Tseng CH
Diabetes Metab; 2017 Oct; 43(5):438-445. PubMed ID: 28438547
[TBL] [Abstract][Full Text] [Related]
12. Dose effect of thiazolidinedione on cancer risk in type 2 diabetes mellitus patients: a six-year population-based cohort study.
Lin HC; Hsu YT; Kachingwe BH; Hsu CY; Uang YS; Wang LH
J Clin Pharm Ther; 2014 Aug; 39(4):354-60. PubMed ID: 24661226
[TBL] [Abstract][Full Text] [Related]
13. Risk of colorectal cancer in type 2 diabetic patients: a population-based cohort study.
Wang JY; Chao TT; Lai CC; Wang CY; Wu VC; Wang SM; Lin HI; Tang SH; Lin HW
Jpn J Clin Oncol; 2013 Mar; 43(3):258-63. PubMed ID: 23288931
[TBL] [Abstract][Full Text] [Related]
14. Association between Gastroenterological Malignancy and Diabetes Mellitus and Anti-Diabetic Therapy: A Nationwide, Population-Based Cohort Study.
Lin CM; Huang HL; Chu FY; Fan HC; Chen HA; Chu DM; Wu LW; Wang CC; Chen WL; Lin SH; Ho SY
PLoS One; 2015; 10(5):e0125421. PubMed ID: 25978841
[TBL] [Abstract][Full Text] [Related]
15. Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial.
Chiasson JL; Josse RG; Gomis R; Hanefeld M; Karasik A; Laakso M;
JAMA; 2003 Jul; 290(4):486-94. PubMed ID: 12876091
[TBL] [Abstract][Full Text] [Related]
16. The Association of Ursodeoxycholic Acid Use With Colorectal Cancer Risk: A Nationwide Cohort Study.
Huang WK; Hsu HC; Liu JR; Yang TS; Chen JS; Chang JW; Lin YC; Yu KH; Kuo CF; See LC
Medicine (Baltimore); 2016 Mar; 95(11):e2980. PubMed ID: 26986110
[TBL] [Abstract][Full Text] [Related]
17. Antihyperglycemic drugs use and new-onset atrial fibrillation in elderly patients.
Chen HY; Yang FY; Jong GP; Liou YS
Eur J Clin Invest; 2017 May; 47(5):388-393. PubMed ID: 28369870
[TBL] [Abstract][Full Text] [Related]
18. Association between irritable bowel syndrome and colorectal cancer: a nationwide population-based study.
Hsiao CW; Huang WY; Ke TW; Muo CH; Chen WT; Sung FC; Kao CH
Eur J Intern Med; 2014 Jan; 25(1):82-6. PubMed ID: 24268837
[TBL] [Abstract][Full Text] [Related]
19. Association between use of oral-antidiabetic drugs and the risk of aortic aneurysm: a nested case-control analysis.
Hsu CY; Su YW; Chen YT; Tsai SH; Chang CC; Li SY; Huang PH; Chen JW; Lin SJ
Cardiovasc Diabetol; 2016 Sep; 15(1):125. PubMed ID: 27585542
[TBL] [Abstract][Full Text] [Related]
20. Insulin enhances and metformin reduces risk of colorectal carcinoma in type-2 diabetes.
Chen CH; Lin CL; Hsu CY; Kao CH
QJM; 2020 Mar; 113(3):194-200. PubMed ID: 31593243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]